Biktarvy

Biktarvy is a prescription medication used to treat HIV-1 infection in adults and children weighing at least 14 kg. It is a single-tablet regimen containing three active ingredients—bictegravir, emtricitabine, and tenofovir alafenamide—which work together to reduce the amount of HIV in the body and help maintain immune function.

Benefits

• A complete, once-daily treatment for HIV-1
  
• Helps lower viral load to undetectable levels with consistent use
  
• Does not require a booster medication
  
•  Generally well-tolerated with a low risk of serious side effects

Dosage

• Taken once daily with or without food
  
• Each tablet contains bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg
  
• Must be taken exactly as prescribed to maintain effectiveness
  
• Do not skip doses, as this may reduce the effectiveness of treatment

Warnings and Precautions

• Not a cure for HIV, but helps manage the infection
  
• Should not be used with certain medications that may interact with its ingredients
  
• May cause or worsen kidney or liver problems in some individuals
  
• Regular monitoring of kidney and liver function is recommended
  
• Not recommended for individuals with severe liver impairment

Usage Instructions

• Swallow the tablet whole with water
  
• Take at the same time every day for best results
  
• If a dose is missed, take it as soon as possible unless it is close to the next scheduled dose
  
• Do not stop taking Biktarvy without consulting your doctor, as this may cause the virus to become resistant

Storage Information

• Store at room temperature in a dry place
  
•  Keep the bottle tightly closed to protect from moisture
  
• Store out of reach of children and pets

Common Side Effects

• Nausea or mild stomach discomfor
  
• Headache or dizziness
  
• Fatigue
  
• Diarrhea
  
• Changes in kidney function (monitored by your doctor)

More information about Biktarvy

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide